Ozempic for Weight Loss – Does It Work and What Are the Risks

Ozempic, a weekly injectable medication containing semaglutide, has become a household name for weight loss — even though it was originally developed to treat type 2 diabetes. Its appetite‑suppressing effects have drawn widespread interest, but many questions remain about how it works, who it is for, and what the real risks are. This guide covers everything you need to know in 2025, from mechanism and dosage to side effects and UK availability.

Used off‑label by people without diabetes, Ozempic is often confused with its higher‑dose sibling Wegovy, which is specifically approved for weight management. The distinction matters for dosing, safety data, and long‑term outcomes. Below we break down the facts based on clinical trials, regulatory statements, and expert commentary.

How Does Ozempic Work for Weight Loss?

• Ozempic is not FDA or MHRA approved for weight loss, but the active ingredient semaglutide is approved as Wegovy.
• Weight loss with Ozempic occurs mainly through appetite suppression and delayed gastric emptying.
• Most weight is lost in the first 12 weeks; plateau after 6 months.
• Side effects are dose‑dependent and often diminish over time.
• Celebrity endorsements like Peter Kay have driven public interest despite medical cautions.

Semaglutide works by mimicking a natural hormone called GLP‑1, which regulates appetite and slows how quickly the stomach empties food. This leads to a feeling of fullness and reduced calorie intake. The effect is consistent across both Ozempic and Wegovy, though the approved doses differ. Medical News Today explains that both contain the same active ingredient but are marketed for different conditions.

What Are the Side Effects and Long‑Term Risks of Ozempic for Weight Loss?

Common gastrointestinal side effects

The most frequently reported adverse effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion, and abdominal discomfort. Sources including Boots Online Doctor and UCHealth note that up to half of patients experience nausea, though it often fades over time.

Serious but rare risks

More severe side effects include pancreatitis, gallbladder disease (gallstones), kidney problems, and severe allergic reactions such as anaphylaxis. Johns Hopkins Medicine also highlights a potential association with thyroid cancer, particularly for people with a family history of medullary thyroid cancer, although the absolute risk remains uncertain.

Long‑term uncertainty

The long‑term safety of Ozempic for weight loss is still being studied. The British Heart Foundation notes that treatment with Wegovy (the higher‑dose semaglutide) is currently limited to two years in its clinical context. Johns Hopkins adds that stopping the medication commonly leads to weight regain, meaning many people may need to stay on the drug long term to maintain results.

How Much Weight Can You Lose on Ozempic?

Average results from clinical data

Weight loss varies by dose, duration, and individual response. In studies of semaglutide, patients using the 1 mg weekly dose (typical for Ozempic) lost around 6–12% of their starting body weight over six months. With the higher 2.4 mg dose used in Wegovy, average losses reach approximately 15% over 15–18 months, as reported by the British Heart Foundation and Boots Online Doctor.

What about 1 month and 6 weeks?

In the first month, users often notice a drop of 2–5 kg, largely due to reduced appetite and calorie intake. By six weeks, some individuals report losses of 5–8 kg, though results vary widely. It is important to remember that weight loss is not linear and can plateau after several months.

Are before‑and‑after pictures reliable?

Photos shared online can be misleading due to differences in lighting, angle, and editing. Clinical trial data provides a more accurate expectation: substantial changes typically occur over months rather than weeks, and the best outcomes are seen when medication is combined with diet and exercise.

If you experience persistent fatigue while taking Ozempic, our article on Why Am I Tired All the Time – Common Causes and Solutions may help identify other factors.

Is Ozempic Approved for Weight Loss?

Regulatory status in the UK

Ozempic is licensed by the MHRA only for the treatment of type 2 diabetes. It is not approved as a weight‑loss medication. However, the active ingredient semaglutide is approved for weight management under the brand name Wegovy, which is prescribed at higher doses (up to 2.4 mg weekly). Superdrug Online Doctor and the NHS both state that off‑label use of Ozempic for weight loss is common but carries different regulatory considerations.

Are there Ozempic tablets?

No. Ozempic is only available as an injectable pen. There is no tablet or oral formulation. An oral semaglutide called Rybelsus exists for diabetes, and it is being studied for weight loss, but it is not the same as Ozempic.

Ozempic vs Wegovy: what’s the difference?

Both drugs contain semaglutide, but Wegovy is dosed at 1.7 mg or 2.4 mg weekly for weight loss, while Ozempic’s maintenance dose is 1 mg (maximum 2 mg in some guidelines). Because of the higher dose, Wegovy generally produces greater weight loss. A direct head‑to‑head trial for weight loss has not been conducted, but comparisons of the two doses consistently show more weight reduction with the higher amount.

Where Can You Get Ozempic for Weight Loss and How Much Does It Cost?

In the UK, Ozempic is available only with a prescription. For diabetes patients, it can be obtained on the NHS (prescription charge applies). For weight loss, it must be sourced privately through online doctors or clinics such as Boots, Superdrug, and Chemist‑4‑U. These providers typically require an online consultation to confirm suitability.

Pricing varies by provider and dose. According to Chemist‑4‑U, Ozempic costs roughly £130–£250 per month, while Wegovy ranges from £99–£199 for lower doses to £169–£300+ for maintenance doses. Some sources quote up to £700 per month for Wegovy in non‑UK contexts, but UK private prices are typically lower.

NHS prescriptions for Ozempic are free per item for eligible patients in England (prescription charges may apply in other parts of the UK), but access is strictly tied to diabetes treatment. For weight loss, patients must pay privately.

What Is the Correct Dosage of Ozempic for Weight Loss?

Standard titration schedule

When prescribed for diabetes, Ozempic is started at 0.25 mg once weekly for four weeks, then increased to 0.5 mg. After another four weeks, the dose may be raised to 1 mg. The maximum dose is 2 mg weekly, but for weight loss the typical maintenance dose used off‑label is 1 mg.

It is not possible to jump to a higher dose quickly; gradual titration is essential to reduce gastrointestinal side effects. Some private providers may follow a similar schedule for off‑label weight loss use.

Can you follow a 6‑week plan?

Some clinics offer accelerated or structured plans lasting six weeks, but these are not standardised. The evidence for such short‑term plans is limited, and the majority of weight loss occurs over several months. Rapid early loss is often water weight rather than fat.

Given the potential for side effects affecting the chest and abdomen, it is worth reading our guide on Left Side Chest Pain: Causes, Symptoms, and When to Worry to distinguish common discomfort from serious symptoms.

How Did Ozempic Become a Weight Loss Drug?

1. 2017 – Ozempic (semaglutide) approved for type 2 diabetes in the US and EU.
2. 2021 – Wegovy (semaglutide 2.4 mg) approved for obesity in the US.
3. 2023 – Wegovy launches in the UK for weight management; off‑label use of Ozempic for weight loss surges.
4. 2024–2025 – Media coverage of celebrity use (Peter Kay, Elon Musk) drives demand; supply shortages affect diabetes patients; regulatory warnings about off‑label prescribing issued.

What Is Known and Unknown About Ozempic for Weight Loss?

Why Did Ozempic Become So Popular for Weight Loss?

Between 2023 and 2025, Ozempic became a cultural phenomenon driven by social media, celebrity mentions, and dramatic appetite suppression. Unlike older weight‑loss drugs, semaglutide is a GLP‑1 agonist originally developed for diabetes. Its off‑label use has created such demand that supply shortages have affected patients who rely on it for diabetes. The regulatory distinction between Ozempic (diabetes) and Wegovy (obesity) is often misunderstood by the public, leading many to seek Ozempic purely for weight loss.

The risk‑reward calculation for using Ozempic for weight loss differs from using approved Wegovy: the lower dose may produce slower weight loss, and long‑term data for weight loss in non‑diabetics is lacking. Cost is similar between the two, but insurance coverage varies.

What Do Experts and Official Sources Say About Ozempic for Weight Loss?

“Ozempic is a weekly injection that helps lower blood sugar… It is not approved for weight loss, but many people experience significant weight loss as a side effect.”

— UC Davis Health, blog post

“Ozempic isn’t licensed as a weight loss treatment. However, the active ingredient in Ozempic, semaglutide, can help to regulate your appetite.”

— Boots Online Doctor, product page

“Weight loss medicines may reduce your appetite and help you feel fuller for longer (GLP‑1 and GIP agonists such as semaglutide, tirzepatide and liraglutide).”

— NHS, overweight and obesity guide

Is Ozempic Right for Weight Loss?

Ozempic can lead to significant weight loss, but it is important to recognise that it is not approved for that purpose in the UK. The approved alternative, Wegovy, offers higher doses and a stronger evidence base for weight management. Anyone considering semaglutide for weight loss should speak with a healthcare professional, weigh the side effects and long‑term uncertainties, and understand that results vary and maintenance is often lifelong.

Frequently Asked Questions About Ozempic for Weight Loss